HIGHLIGHTS
- who: UC Irvine and collaborators from the University of California have published the article: UC Irvine, in the Journal: (JOURNAL) of August/13,/2012
- what: The authors report according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses and MOOSE (Meta-analysis of Observational Studies in Epidemiology) statements.9-11 Eligibility Criteria
- how: All dosages and frequencies of rasburicase were included in this review and these were considered the active group. If heterogeneity was detected (I2 ⬎ 40%) the authors explored it further using patient and trial characteristics in moderator analyses . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.